DYAI Stock Analysis: Buy, Sell, or Hold?
DYAI - Dyadic International, Inc.
$0.94
-0.08 (-7.79%)
▼
5d:
+26.92%
30d:
+36.36%
90d:
+10.37%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When DYAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: DYAI is 9.4% above its trading range ($0.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: DYAI is 9.4% above its trading range ($0.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: DYAI is currently trading at $0.94, which is considered extended relative to its 30-day fair value range of $0.69 to $0.86. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.2) compared to its historical average (52.8). Remarkably, the market is currently pricing in an annual earnings decline of 18.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DYAI is in a downtrend. The price is approaching resistance at $0.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 7.8% recently.
Market Sentiment: DYAI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+538.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DYAI is in a downtrend. The price is approaching resistance at $0.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 7.8% recently.
Market Sentiment: DYAI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+538.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.69 -
$0.86
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BEARISH: Price extended above range (+9.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.8%)
- BULLISH: Trading 538.0% below Wall St target ($6.00)
Trading Range Analysis
30-Day Trading Range
$0.69 -
$0.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$0.83
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.24
Wall Street Target
$6.00
(+538.0%)
Revenue Growth (YoY)
182.3%
Profit Margin
-191.5%
Valuation Discount vs History
-18.8% cheaper
PE vs Historical
28.2 vs 52.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.8%
(market-implied from PE analysis)
1-Year Target
$0.85
(-10%)
2-Year Target
$0.76
(-19%)
3-Year Target
$0.69
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→53)
$1.28
(+36%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.2 to 52.8
Stabilization Target:
$1.76
(+86.9%)
PE Expansion Potential:
+86.9%
Share & Embed Analysis
Last updated: July 02, 2026 10:34 PM ET
Data refreshes hourly during market hours. Next update: 11:34 PM
Data refreshes hourly during market hours. Next update: 11:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 45 HOLD |
